20 January 2021
Researchers in the Simmons lab chart the embryonic origins and appearance of diverse intestinal cellular compartments, with important implications for intestinal diseases.
27 November 2020
Study reveals what happens to blood cell production during the ageing process, which could help identify new therapeutic targets.
25 November 2020
The Drakesmith group finds that low blood serum iron levels can inhibit T-cell and B-cell immune responses to vaccines and infections.
16 November 2020
A trial of a new inhaled antiviral drug for COVID-19 has shown positive results and the drug is now moving into a larger international phase 3 trial of hospitalised patients. MRC HIU's Professor Ling-Pei Ho is one of the main co-authors on the paper.
8 October 2020
A free game launched today allows players to role-play the deployment of a virtual vaccine to help to halt the global spread of a viral pandemic.
18 September 2020
A team of researchers at the MRC HIU have played a major role in the development and validation of an innovative approach to the discovery of potent therapeutic antibodies, which could help to lay the foundations for a new cancer drug.
10 September 2020
New Nature paper reveals discovery of a genetic vulnerability in nearly 10% of breast cancer tumours and how this can be targeted to selectively kill cancer cells.
4 September 2020
New Nature Immunology paper finds strong T cell responses in recovered COVID-19 patients
25 August 2020
The awardees for the second round of the University of Oxford’s Enriching Engagement funding scheme have been announced, including six projects from across the Medical Sciences Division.
24 August 2020
Researchers have identified a mechanism by which multidrug-resistant Salmonella Typhimurium strains evade immune system detection. The strains recently emerged in sub-Saharan Africa and are a major cause of ill-health and death in the region. Harnessing this mechanism may offer a therapeutic strategy to improve immunity